• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主动监测早期前列腺癌男性的连续活检中肿瘤体积的变化。

Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer.

机构信息

Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143-1695, USA.

出版信息

J Urol. 2011 Nov;186(5):1825-9. doi: 10.1016/j.juro.2011.06.055. Epub 2011 Sep 25.

DOI:10.1016/j.juro.2011.06.055
PMID:21944082
Abstract

PURPOSE

We described changes in tumor volume on serial biopsies during an extended period in men on active surveillance.

MATERIALS AND METHODS

The study cohort included men diagnosed with prostate cancer between 1998 and 2010 enrolled in active surveillance with 6 or more months of followup. Change in volume over time was assessed as change in percent cores positive, percent cancer in 1 biopsy core and the doubling of total cancer volume (mm). Logistic regression was used to determine the association between grade and volume progression.

RESULTS

A total of 399 men met the study inclusion criteria. Mean patient age was 61.8 years old and 313 (78%) had low risk disease. Overall 231 (58%) men had stable disease on repeat biopsies. There were 39 (10%) men with a volume increase, defined by an increase to more than 33% cores involved or an increase in maximum single core positive to more than 50%, and there were 44 (11%) with an increase in volume and grade. Approximately 10% of men experienced a decrease in cancer volume. On multivariate analysis there was a significant association between grade and volume progression on any biopsy (OR 3.07), and a doubling of tumor length (mm) at 5 years (OR 6.30).

CONCLUSIONS

Prostate cancer volume increases and decreases at a similar rate of 10% per biopsy. An increase in tumor volume is associated with an increase in cancer grade on early repeat biopsies. However, there is a large degree of variation in cancer volume over time.

摘要

目的

我们描述了在主动监测期间对男性进行多次活检时肿瘤体积的变化。

材料和方法

研究队列包括 1998 年至 2010 年间被诊断患有前列腺癌并接受主动监测且随访时间超过 6 个月的男性。通过改变核心阳性百分比、单次活检核心中的癌症百分比和总癌症体积(mm)的两倍来评估随时间变化的体积变化。使用逻辑回归来确定分级和体积进展之间的关联。

结果

共有 399 名男性符合研究纳入标准。患者平均年龄为 61.8 岁,313 名(78%)为低危疾病。总体而言,231 名(58%)男性在重复活检时表现为稳定疾病。有 39 名(10%)男性的体积增加,定义为涉及的核心增加到 33%以上或最大单核心阳性增加到 50%以上,有 44 名(11%)男性的体积和分级增加。大约 10%的男性经历了癌症体积的减少。在多变量分析中,任何活检时分级和体积进展之间存在显著关联(OR 3.07),并且在 5 年内肿瘤长度(mm)增加一倍(OR 6.30)。

结论

前列腺癌体积在每次活检时以相似的 10%的速度增加和减少。肿瘤体积的增加与早期重复活检时癌症分级的增加相关。然而,在一段时间内,癌症体积存在很大的变化。

相似文献

1
Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer.主动监测早期前列腺癌男性的连续活检中肿瘤体积的变化。
J Urol. 2011 Nov;186(5):1825-9. doi: 10.1016/j.juro.2011.06.055. Epub 2011 Sep 25.
2
The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management.多部位扩大活检男性患者肿瘤体积与阳性活检核心数之间的关系:对观察等待管理的意义
J Urol. 2005 Dec;174(6):2164-8, discussion 2168. doi: 10.1097/01.ju.0000181211.49267.43.
3
Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.主动监测患者中与前列腺癌进展相关的活检特征:三种统计模型的比较。
BJU Int. 2013 Apr;111(4):574-9. doi: 10.1111/j.1464-410X.2012.11127.x. Epub 2012 May 4.
4
The independent impact of extended pattern biopsy on prostate cancer stage migration.扩展模式活检对前列腺癌分期迁移的独立影响。
J Urol. 2005 Nov;174(5):1789-93; discussion 1793. doi: 10.1097/01.ju.0000177465.11299.02.
5
Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.在重复活检时诊断出的前列腺癌体积较小,且高级别癌的可能性较低。
J Urol. 2008 Oct;180(4):1325-9; discussion 1329. doi: 10.1016/j.juro.2008.06.022. Epub 2008 Aug 15.
6
Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.222例前列腺癌根治术标本的系统活检与组织学特征之间的关系:对不可触及前列腺癌患者肿瘤意义的预测不足
J Urol. 2001 Jul;166(1):104-9; discussion 109-10.
7
A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.一种预测低体积/低级别前列腺癌的列线图:一种用于选择患者进行主动监测的工具。
Cancer. 2007 Dec 1;110(11):2441-7. doi: 10.1002/cncr.23055.
8
Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients.对诊断后前列腺特异性抗原动力学的综合分析作为主动监测患者前列腺癌进展的预测指标。
BJU Int. 2013 Mar;111(3):396-403. doi: 10.1111/j.1464-410X.2012.11295.x. Epub 2012 Jun 15.
9
The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.前列腺穿刺活检标本中癌阳性核心的百分比强烈预测根治性前列腺切除术中的肿瘤分期和体积。
J Urol. 2000 Jan;163(1):174-8.
10
Active surveillance for the management of prostate cancer in a contemporary cohort.当代队列中前列腺癌管理的主动监测
Cancer. 2008 Jun 15;112(12):2664-70. doi: 10.1002/cncr.23502.

引用本文的文献

1
Incorporating the [68Ga]Ga-PSMA PET/CT PRIMARY score into the selection criteria for prostate cancer patients eligible for active surveillance.将[68Ga]镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描([68Ga]Ga-PSMA PET/CT)原发性评分纳入适合积极监测的前列腺癌患者的选择标准。
Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1464-1466. doi: 10.1007/s00259-024-06642-9.
2
Prediction of clinically significant prostate cancer by [ Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance.[68Ga]Ga-PSMA-11 PET/CT 预测临床显著前列腺癌:主动监测患者选择的潜在工具。
Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1467-1475. doi: 10.1007/s00259-023-06556-y. Epub 2023 Dec 19.
3
Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer.
磁共振成像-经直肠超声融合引导前列腺活检:当前前列腺癌的癌症检测现状和前列腺癌个体化医学的前景。
Investig Clin Urol. 2019 Jan;60(1):4-13. doi: 10.4111/icu.2019.60.1.4. Epub 2018 Dec 27.
4
In-bore MRI-guided biopsy: can it optimize the need for periodic biopsies in prostate cancer patients undergoing active surveillance? A pilot test-retest reliability study.磁共振成像引导下的穿刺活检:能否优化接受主动监测的前列腺癌患者定期活检的必要性?一项初步重测信度研究。
Br J Radiol. 2018 Apr;91(1084):20170603. doi: 10.1259/bjr.20170603. Epub 2018 Feb 13.
5
Population-based study of grade progression in patients who harboured Gleason 3 + 3.基于人群的研究显示,存在 Gleason 3+3 的患者出现分级进展。
World J Urol. 2017 Nov;35(11):1689-1699. doi: 10.1007/s00345-017-2047-z. Epub 2017 May 12.
6
The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer.PI-RADSv2 评分和定量表观扩散系数在考虑主动监测前列腺癌的患者中预测确认性前列腺活检结果的性能。
Abdom Radiol (NY). 2017 Jul;42(7):1968-1974. doi: 10.1007/s00261-017-1086-7.
7
Image-based monitoring of targeted biopsy-proven prostate cancer on active surveillance: 11-year experience.基于图像的主动监测中经靶向活检证实的前列腺癌监测:11年经验
World J Urol. 2016 Feb;34(2):221-7. doi: 10.1007/s00345-015-1619-z. Epub 2015 Jun 21.
8
Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer.对接受前列腺癌主动监测的男性特定肿瘤部位进行电子追踪的初步经验。
Urol Oncol. 2014 Oct;32(7):952-7. doi: 10.1016/j.urolonc.2014.04.003. Epub 2014 Jul 11.
9
Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer.主动监测早期前列腺癌男性的有意义终点和结局。
Curr Opin Urol. 2014 May;24(3):288-92. doi: 10.1097/MOU.0000000000000039.
10
Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer.
Int J Clin Oncol. 2014;19(3):531-5. doi: 10.1007/s10147-013-0584-z. Epub 2013 Jun 22.